	Effect of SMS Reminders on Medication Adherence in Schizophrenia: A Quasi-Experimental Study in Nigeria. Niger Med J Yakubu AA, Bashar SM, Aveka AI, Murinyi MM, Khalid S, Yakasai BA. PMID: 42553841 [PubMed - as supplied by publisher]
	Evaluation of a hybrid asynchronous-synchronous delivery model for family intervention in psychosis: the psychosis REACH program. Front Digit Health Kopelovich SL, Blank J, Vaswani-Bye A, Shepard V, Buckland HT, Hardy K, Turkington D. PMID: 42553243 [PubMed]
	Latest developments in the use of e-cigarettes by people with schizophrenia spectrum disorders who smoke: a scoping review. Front Psychiatry Caponnetto P, Pratt S, Bellanca CM, Vitale NM, Prezzavento GC, La Rosa GRM, Adebisi YA, Nilforooshan R, John I, Fakhrou A, Petralia A, Signorelli MS, Pikirenia U, Testoni I, Cavallaro R, Bosia M, Polosa R. PMID: 42553197 [PubMed]
	CB1 receptor-enriched functional connectivity analysis revealed target-specific modulation by cannabidiol in early psychosis. J Psychopharmacol Lombardi G, Shatalina E, O'Neill A, Wilson R, Mehta M, Bhattacharyya S. PMID: 42552898 [PubMed - as supplied by publisher]
	The Mediating Role of Metacognitive Beliefs in Self-Compassion and Schizophrenia Recovery. Brain Behav Darwish SS, Al-Sarahneh A, Dibas M, Ali A, Hamed A, Barakat A, Othman A, ElBoraie H, Hamzaa H, Ali W. PMID: 42552873 [PubMed - indexed for MEDLINE]
	Feasibility Trial of a Health Behaviours Promotion Group for Youth at Clinical High Risk for Psychosis. Early Interv Psychiatry Ruiz-Yu B, Diaz T, Hernandez D, Zinberg J, Miklowitz DJ, Bearden CE. PMID: 42552232 [PubMed - indexed for MEDLINE]
	Astroglial dysregulation and gliotransmitter imbalance in schizophrenia. Int Rev Neurobiol Babu Deva Irakkam MP, Kandasamy M. PMID: 42552049 [PubMed - indexed for MEDLINE]
	Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm. Br J Pharmacol Morris BJ, Pratt JA. PMID: 42551974 [PubMed - as supplied by publisher]
	Evolving patterns of antipsychotic use and polypharmacy for schizophrenia in Hong Kong: a 21-year longitudinal study. Psychiatry Res Deng EK, Yan VK, Leung SM, Wei Y, Lee KJ, Huang C, Kan CK, Lai FTT, Wong IC, Chen EYH, Chan EW. PMID: 42551239 [PubMed - as supplied by publisher]
	Medium-term prediction of clinically relevant outcomes in first-episode schizophrenia patients. Schizophr Res Bakstein E, Kudelka J, Schneider J, Slovakova A, Fialova M, Ihln M, Furstova P, Hlinka J, Spaniel F. PMID: 42551145 [PubMed - as supplied by publisher]
	Correlates of Engagement and Associations With Outcomes in a Cannabis Harm-Reduction Mobile App for Youth With First-Episode Psychosis: Exploratory Analysis of the CHAMPS Pilot Randomized Controlled Trial. JMIR Form Res Mahroug A, Lachance-Touchette P, Coronado-Montoya S, Abdel-Baki A, Côté J, Crocker C, Crockford DN, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lecomte T, L'Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D. PMID: 42550986 [PubMed - indexed for MEDLINE]
	Accelerated, Neuronavigated Neuromodulation for Negative Symptoms in Schizophrenia: Protocol for a Randomized Controlled Pilot Trial. Sante Ment Que Choucroun A, Roy O, Potvin S, Palaniyappan L, Zeramdini N, Aiyaar A, Picard K, Zanjani S, Parekh D, Markessinis M, Friesen T, Zamorano T, Diaconescu A, Lepage M, Powers A, Shah J, Zavaglia E, Benrimoh D. PMID: 42550441 [PubMed - indexed for MEDLINE]
	[Spirituality and cortisol in people living with schizophrenia: An exploratory study]. Sante Ment Que Poulin A, Lupien S, Consortium Signature. PMID: 42550433 [PubMed - indexed for MEDLINE]
	Efficacy and safety of add-on topiramate vs. metformin on cardiometabolic profile in patients of schizophrenia on atypical antipsychotics with metabolic syndrome: an active-controlled, rater-blinded, parallel-design randomized controlled trial. Eur Arch Psychiatry Clin Neurosci Chakraborty R, Mohapatra D, Biswas T, Ramasubbu MK, Maiti R, Mishra A, Mishra BR. PMID: 42550195 [PubMed - as supplied by publisher]
	Investigating changes in the blood-brain barrier in schizophrenia spectrum disorders: design and methodology of a longitudinal dynamic contrast-enhanced MRI study. Eur Arch Psychiatry Clin Neurosci Wendl A, Zöllinger A, Lukas D, Lutz I, Schamberger M, Lobinger C, Maurus I, Hasan A, Wagner E, Falkai P, Schmitt A, Raabe FJ, Schiltz K, Seelos K, Stöcklein S, Boudriot E, Yakimov V, Roell L, Keeser D, Moussiopoulou J. PMID: 42550194 [PubMed - as supplied by publisher]
	Untreated Psychosis and Healthcare-Seeking Behaviour in Pakistan: A Qualitative Study With Young People, Carers, Traditional Healers, and Healthcare Professionals. Early Interv Psychiatry Sanauddin N, Dikomitis L, Khan AJ, Azeemi MMUH, Khan MF, Sheikh S, Fonseka N, Milner A, Shah SMU, Azeemi IT, Hamid S, Jamal SF, Sargeant A, Farooq S. PMID: 42549551 [PubMed - indexed for MEDLINE]
	Anorexia Nervosa, Schizophrenia, and Autism Spectrum Disorder: A Review of the Role of Tanycytes in Individual and Social Behavior. Cureus Dalvi P, Kelly O, Grady L, Carris N, Sullivan J, Liu H. PMID: 42549257 [PubMed]
	Trial-History Effects During WCST in Treatment-Resistant Schizophrenia. Neuropsychopharmacol Rep Sawagashira R, Toyomaki A, Watanabe H, Hashimoto N, Kato TA. PMID: 42548112 [PubMed - indexed for MEDLINE]
	Real-world antipsychotic prescribing patterns and mortality in schizophrenia: a registry cohort study from China. Epidemiol Psychiatr Sci He H, Dai L, Ma S, Jia FJ, Chen B, Lin H, Wang SB, Tan W, Li J. PMID: 42548073 [PubMed - indexed for MEDLINE]
	High prevalence of tau pathologies in late-onset psychosis: A PET study. Mol Psychiatry Kubota M, Kurose S, Tagai K, Momota Y, Ichihashi M, Endo H, Seki C, Moriguchi S, Yamamoto Y, Kataoka Y, Goto R, Tamura T, Shiwaku H, Matsuoka K, Suzuki H, Onaya M, Tokuda T, Uchida H, Takahashi H, Kawamura K, Zhang MR, Higuchi M, Takahata K. PMID: 42547799 [PubMed - as supplied by publisher]

Articles 1 - 20 / 69510

Page 1 of 3476



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy